Literature DB >> 24306434

Limb swelling in a pediatric sickle cell patient after revaccination with pneumococcal vaccine.

Calvin C Daniels1, Chasity M Shelton, Patricia J Bass, Winfred C Wang, Katie J Suda.   

Abstract

CASE (DESCRIPTION): This report describes an incident of limb swelling after revaccination with the 23-valent pneumococcal polysaccharide vaccine (PPSV23). A 5-year old female with sickle cell disease experienced severe arm swelling with edema to the extent that it was difficult to put a shirt over the arm. The day prior, she received PPSV23 concomitantly with the meningococcal vaccine. She had received the PPSV23 vaccine 2.5 years prior to the event. The patient was managed with analgesics, antiemetics, and antibiotic prophylaxis and the arm swelling resolved 24 h later. A decreased length of time between revaccination and concurrent administration with the meningococcal vaccine could have contributed.
CONCLUSION: Although rare, limb swelling after revaccination could be a concern in special at-risk populations where repeated vaccination is necessary for pneumococcal protection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24306434     DOI: 10.1007/s11096-013-9888-3

Source DB:  PubMed          Journal:  Int J Clin Pharm


  11 in total

1.  Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population.

Authors:  Lisa A Jackson; Jennifer C Nelson; Cynthia G Whitney; Kathleen M Neuzil; Patti Benson; Darren Malais; James Baggs; John Mullooly; Steve Black; David K Shay
Journal:  Vaccine       Date:  2005-08-10       Impact factor: 3.641

2.  Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data.

Authors:  Katrin S Kohl; Wikke Walop; Jane Gidudu; Leslie Ball; Scott Halperin; Sandra Jo Hammer; Paul Heath; Frederick Varricchio; Edward Rothstein; Anne Schuind; Renald Hennig
Journal:  Vaccine       Date:  2007-05-11       Impact factor: 3.641

3.  Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease.

Authors:  L Vernacchio; E J Neufeld; K MacDonald; S Kurth; S Murakami; C Hohne; M King; D Molrine
Journal:  J Pediatr       Date:  1998-08       Impact factor: 4.406

4.  Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-09-03       Impact factor: 17.586

5.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

6.  Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  J Pekka Nuorti; Cynthia G Whitney
Journal:  MMWR Recomm Rep       Date:  2010-12-10

7.  Pneumococcal polysaccharide immunization of children with sickle cell disease. I. Clinical reactions to immunization and relationship to preimmunization antibody.

Authors:  G D Overturf; J G Rigau-Perez; J Selzer; R J Field; D Powars; E J Pang; C Uy; G Honig; J Weiss; L Chan; B Portnoy
Journal:  Am J Pediatr Hematol Oncol       Date:  1982

8.  Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials.

Authors:  M J Fine; M A Smith; C A Carson; F Meffe; S S Sankey; L A Weissfeld; A S Detsky; W N Kapoor
Journal:  Arch Intern Med       Date:  1994 Dec 12-26

9.  Reactions to booster pneumococcal vaccination in patients with sickle cell disease.

Authors:  J G Rigau-Perez; G D Overturf; L S Chan; J Weiss; D Powars
Journal:  Pediatr Infect Dis       Date:  1983 May-Jun

10.  Safety of revaccination with pneumococcal polysaccharide vaccine.

Authors:  L A Jackson; P Benson; V P Sneller; J C Butler; R S Thompson; R T Chen; L S Lewis; G Carlone; F DeStefano; P Holder; T Lezhava; W W Williams
Journal:  JAMA       Date:  1999-01-20       Impact factor: 56.272

View more
  2 in total

1.  Adverse Reactions to Pneumococcal Vaccine in Pediatric and Adolescent Patients with Sickle Cell Disease.

Authors:  Jin Han; Opeyemi Kemiki; Lewis L Hsu; Angela E Rivers
Journal:  Pharmacotherapy       Date:  2015-06-19       Impact factor: 4.705

Review 2.  A Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein Antigens.

Authors:  Calvin C Daniels; P David Rogers; Chasity M Shelton
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.